Skip to main content

The Clinical Haematology Department at the Jules Bordet Institute specialises in determining and treating malignant haemopathies (blood cancers). 
The Jules Bordet Institute is committed to treating these diseases with the aim of providing the patient with individualised care of the highest quality in terms of treatment and support.

In addition to treating malignant haemopathies, the Institute is also engaged in treating adolescents and young adults (AYAs) and  rare haematological cancers while developing innovative and complex techniques and therapies, including   cell therapies.

The Institute’s mission covers 3 main university fields: clinical, research and teaching. Multidisciplinarity, in both its diagnostic and therapeutic approaches, forms an inherent part of all decisions concerning the patient.  

Research projects

Participation of the Hematology Department in research projects with the Clinical cellular therapy research laboratory (LTCC)
 

Project 1

Protocoles de recherche clinique académiques et pharmaceutiques
  • Project leaders : Drs M. Maerevoet and N. Meuleman
  • Funding : Fonds Ariane, Pharma

Project 2

Interculturality and Transplantation  
  • Project leaders : Sandra Michiels, Patrick Crombez
  • Collaboration : MASCC (International, Prof Klastersky)
  • Funding : «Association Jules Bordet» / BHS / Fondation Kisane

Project 3

Role of radio-immunotherapy in myeloma

Project 4

ÉVALUATION DES TROUBLES COGNITIFS LIÉS AU CANCER PAR DES TESTS NEUROPSYCHOLOGIQUES ET DES TECHNIQUES D’IMAGERIE FONCTIONNELLES CHEZ LES ADOLESCENTS ET JEUNES ADULTES (AJA) ATTEINTS DE LYMPHOMES
  • Project leader : Alice Wolfromm

    Our team

    • Hematologists
      • Pr Nathalie MEULEMAN, Head of Department
      • Pr Virginie DE WILDE, Head of Department (associated)
      • Dr Fabio ANDREOZZI
      • Pr Samantha BENGHIAT
      • Dr Sarah BUNTINX
      • Dr Martin COLARD
      • Dr Julie DALLEMAGNE
      • Pr Philippe LEWALLE
      • Dr Marie MAEREVOET
      • Dr Fulvio MASSARO
      • Dr Ornella RIZZO
      • Dr Adriano SALAROLI
      • Dr Chloé SPILLEBOUDT
      • Dr Marie VERCRUYSSEN
      • Pr Sebastian WITTNEBEL
      • Dr Alice WOLFROMM
         
    • Consultants
      • Pr Dominique BRON
      • Dr Axelle GILLES
      • Dr Françoise LE MOINE
      • Pr Serge MOTTE
         

    THE TEAM

    25/04/2023

     Scientific publications

    Linking clinical and population-based data in older patients with cancer in Belgium: Feasibility and clinical outcomes.

    Authors : Depoorter V, Vanschoenbeek K, Decoster L, De Schutter H, Debruyne PR, De Groof I, Bron D, Cornélis F, Luce S, Focan C, Verschaeve V, Debugne G, Langenaeken C, Van den Bulck H, Goeminne JC, Teurfs W, Jerusalem G, Schrijvers D, Petit B, Rasschaert M, Praet JP, Vandenborre K, Milisen K, Flamaing J, Kenis C, Verdoodt F, Wildiers H
    Year : 2023
    Journal : J Geriatr Oncol
    Pages : 101428

    Potential of Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Natural Nanocarriers: Concise Review.

    Authors : Draguet F, Bouland C, Dubois N, Bron D, Meuleman N, Stamatopoulos B, Lagneaux L
    Year : 2023
    Journal : Pharmaceutics
    Volume : 15

    Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis.

    Authors : Martins-Branco D, Nader-Marta G, Tecic Vuger A, Debien V, Ameye L, Brandão M, Punie K, Loizidou A, Willard-Gallo K, Spilleboudt C, Awada A, Piccart M, de Azambuja E
    Year : 2022
    Journal : J Cancer Res Clin Oncol
    Pages : 1-6

    Bioscreening and pre-clinical evaluation of the impact of bioactive molecules from Ptychotis verticillata on the multilineage potential of mesenchymal stromal cells towards immune- and inflammation-mediated diseases.

    Authors : Bouhtit F, Najar M, Rahmani S, Melki R, Najimi M, Sadki K, Boukhatem N, Twizere JC, Meuleman N, Lewalle P, Lagneaux L, Merimi M
    Year : 2022
    Journal : Inflamm Res
    Volume : 71
    Pages : 887-898

    HTLV-1-related adult T-cell leukemia/lymphoma: insights in early detection and management.

    Authors : Wolf S, Vercruyssen M, Cook L
    Year : 2022
    Journal : Curr Opin Oncol
    Volume : 34
    Pages : 446-453